Small-molecule ligands that modulate the action of retinoic acid receptors (RARs) and retinoid X receptors (RXRs) — members of the nuclear receptor superfamily — have been used as anticancer drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback